|
||||||||
Media Home | Contact Us |
|
|
|
PRESS CONTACT: |
Data were collected from the national family planning program, which serves predominantly low-income women. One percent to 5 percent of women attending these clinics said they used contraceptive products containing N-9, including vaginal films and inserts, gels, jellies and foams. This study measures N-9 usage prior to recommendations against the use of N-9 for STD and HIV prevention. However, the findings indicate that as of a few years ago, N-9 was being used as a contraceptive among some women in the U.S. Recently published studies conducted in commercial sex workers have shown that N-9 contraceptives do not protect against HIV, gonorrhea or chlamydia infection. Providers of family planning services should therefore ensure women at-risk for HIV/STDs are counseled that N-9 contraceptives do not protect against these infections.
PRESS CONTACT: Ilin Chuang, MD CDC, National Center for Infectious Diseases (404) 639–2215 |
Most surveyed clinical laboratories were using appropriate methods for pneumococcal susceptibility testing; however, some inconsistencies with the National Committee for Clinical Laboratory Standards (NCCLS) guidelines were noted. For isolates from patients with potentially life-threatening infections, laboratories should bypass oxacillin disk screening; 53 percent of surveyed laboratories reported performing oxacillin disk screening. Laboratories should also test pneumococcal isolates for fluoroquinolones, an antibiotic increasingly used to treat for common pneumonia; only 40 percent of laboratories in this survey performed susceptibility testing against fluoroquinolones. Because treatment decisions may vary based on clinical syndrome and severity of illness, exact minimum inhibitory concentrations (MICs) in combination with interpretations can assist clinicians with therapeutic decisions.
PRESS CONTACT: Kristy Lillibridge, DMV CDC, National Center for Infectious Diseases (404) 498–1634 |
There was potential for exposure to other individuals during an infant's travel from Moscow to the United States, including the orphanage in Russia, the US embassy in Russia, and flights from Moscow to North Carolina via New York. CDC is working with the airlines to identify passengers who might have been exposed to the patient during the flight to the United States. Since pertussis illness can be mild in older children and adults and may go unrecognized, health officials are concerned about the risk of transmission to infants who are at higher risk for severe illness and death. Those who have been exposed should receive chemoprophylaxis with antibiotics to prevent transmission.
CDC Home | Search | Health Topics A-Z This page last reviewed May 10, 2002 United States Department of Health and Human Services |